iNtRON Biotechnology, Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.intron.co.kr

Country

South Korea

Exchange

KOSDAQ

Founded 1999Seongnam-si, South Korea

iNtRON Biotechnology develops novel biopharmaceutical drugs in South Korea. It develops bacteriophage and endolysin based drugs through itLysin and IMPA platform. Founded in 1999, the company is headquartered in Seongnam-si, South Korea.

Key Stats

52-Week Range

₩2275.00₩7010.00

Beta0.05

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.